Literature DB >> 18655788

Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth.

Kotoyo Fujiki1, Eva-Maria Duerr, Hirotoshi Kikuchi, Aylwin Ng, Ramnik J Xavier, Yusuke Mizukami, Takaaki Imamura, Matthew H Kulke, Daniel C Chung.   

Abstract

BACKGROUND & AIMS: The molecular alterations that underlie carcinoid tumor pathogenesis remain poorly defined. The homeobox gene HOXC6 was highly up-regulated in human gastrointestinal carcinoid tumors, and we sought to define its pathogenic role.
METHODS: The functional and physical properties of Hoxc6 were investigated by establishing carcinoid cells that stably overexpressed Hoxc6 or were deficient in Hoxc6. Cellular proliferation assays, luciferase reporter assays, Western blotting, immunoprecipitation, DNA affinity precipitation, and DNA microarray studies were performed.
RESULTS: Expression of Hoxc6 in cultured human BON1 carcinoid cells enhanced their proliferation, and knock-down of Hoxc6 inhibited their growth. Hoxc6 activated the oncogenic activator protein-1 signaling pathway through a physical interaction with JunD. Mutations in the homeodomain of Hoxc6 blocked this interaction and inhibited proliferation of carcinoid cells. Of note, Hoxc6 induced the expression of genes that characteristically are up-regulated in carcinoid tumors, including neurotensin and connective tissue growth factor.
CONCLUSIONS: A novel molecular pathway has been identified that links Hoxc6 with oncogenic signaling through the activator protein-1 pathway in carcinoid tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655788      PMCID: PMC3777410          DOI: 10.1053/j.gastro.2008.06.034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  34 in total

1.  Cloning and expression of a new HOXC6 transcript encoding a repressing protein.

Authors:  A Chariot; V Castronovo; P Le; C Gillet; M E Sobel; J Gielen
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

2.  The oncogenic potential of an activated Hox-2.4 homeobox gene in mouse fibroblasts.

Authors:  D Aberdam; V Negreanu; L Sachs; C Blatt
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

3.  The oncogenic potential of deregulated homeobox genes.

Authors:  C C Maulbecker; P Gruss
Journal:  Cell Growth Differ       Date:  1993-05

4.  HOXB7 constitutively activates basic fibroblast growth factor in melanomas.

Authors:  A Caré; A Silvani; E Meccia; G Mattia; A Stoppacciaro; G Parmiani; C Peschle; M P Colombo
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint.

Authors:  T Kawabe; A J Muslin; S J Korsmeyer
Journal:  Nature       Date:  1997-01-30       Impact factor: 49.962

6.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

7.  Synergistic induction of neurotensin gene transcription in PC12 cells parallels changes in AP-1 activity.

Authors:  B P Bullock; G P McNeil; P R Dobner
Journal:  Brain Res Mol Brain Res       Date:  1994-12

8.  Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer.

Authors:  Colleen D McCabe; Demetri D Spyropoulos; David Martin; Carlos S Moreno
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

Review 9.  Carcinoid--a comprehensive review.

Authors:  Isac I Schnirer; James C Yao; Jaffer A Ajani
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

10.  Isolation and expression of a new mouse homeobox gene.

Authors:  P T Sharpe; J R Miller; E P Evans; M D Burtenshaw; S J Gaunt
Journal:  Development       Date:  1988-02       Impact factor: 6.868

View more
  8 in total

1.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

2.  HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expression.

Authors:  Sung-Min Moon; Soo-A Kim; Jung-Hoon Yoon; Sang-Gun Ahn
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

3.  Noninvasive detection of candidate molecular biomarkers in subjects with a history of insulin resistance and colorectal adenomas.

Authors:  Chen Zhao; Ivan Ivanov; Edward R Dougherty; Terryl J Hartman; Elaine Lanza; Gerd Bobe; Nancy H Colburn; Joanne R Lupton; Laurie A Davidson; Robert S Chapkin
Journal:  Cancer Prev Res (Phila)       Date:  2009-05-26

4.  Silencing homeobox C6 inhibits colorectal cancer cell proliferation.

Authors:  Meiling Ji; Qingyang Feng; Guodong He; Liangliang Yang; Wentao Tang; Xinyuan Lao; Dexiang Zhu; Qi Lin; Pingping Xu; Ye Wei; Jianmin Xu
Journal:  Oncotarget       Date:  2016-05-17

5.  Wolf-Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation.

Authors:  Chuan Yu; Xiaomin Yao; Linjie Zhao; Ping Wang; Qian Zhang; Chengjian Zhao; Shaohua Yao; Yuquan Wei
Journal:  Neoplasia       Date:  2017-06-24       Impact factor: 5.715

6.  HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas.

Authors:  Hui Huang; Zhengyuan Huo; Jiantong Jiao; Wei Ji; Jin Huang; Zheng Bian; Bin Xu; Junfei Shao; Jun Sun
Journal:  Cancer Cell Int       Date:  2022-04-29       Impact factor: 6.429

7.  Multitranscriptome analyses of keloid fibroblasts reveal the role of the HIF-1α/HOXC6/ERK axis in keloid development.

Authors:  Qi Wang; Yixiu Zhong; Zhijia Li; Dingheng Zhu; Hongyan Lu; Pingjiao Chen; Changxing Li; Xuebiao Peng; Qian Li; Kang Zeng
Journal:  Burns Trauma       Date:  2022-05-09

8.  3-M syndrome: a growth disorder associated with IGF2 silencing.

Authors:  P G Murray; D Hanson; T Coulson; A Stevens; A Whatmore; R L Poole; D J Mackay; G C M Black; P E Clayton
Journal:  Endocr Connect       Date:  2013-11-11       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.